ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,031,000 | +327.8% | 53,300 | +338.9% | 0.05% | +380.0% |
| Q2 2022 | $241,000 | -57.6% | 12,143 | -36.4% | 0.01% | -50.0% |
| Q1 2022 | $568,000 | +43.1% | 19,082 | +11.7% | 0.02% | +42.9% |
| Q4 2021 | $397,000 | -25.5% | 17,082 | 0.0% | 0.01% | -39.1% |
| Q3 2021 | $533,000 | +2.5% | 17,082 | +15.6% | 0.02% | +9.5% |
| Q2 2021 | $520,000 | -11.0% | 14,774 | -10.9% | 0.02% | -12.5% |
| Q1 2021 | $584,000 | +81.4% | 16,574 | +93.3% | 0.02% | +100.0% |
| Q4 2020 | $322,000 | -91.8% | 8,574 | -92.7% | 0.01% | -93.5% |
| Q3 2020 | $3,930,000 | – | 117,800 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |